# A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

> **NCT00770341** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 122 (actual)

## Conditions studied

- Staphylococcal Infection

## Interventions

- **DRUG:** Daptomycin 4 mg/kg
- **DRUG:** Comparator: vancomycin
- **DRUG:** Daptomycin 6 mg/kg

## Key facts

- **NCT ID:** NCT00770341
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2017-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770341, "A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00770341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*